# Selection of Farnesoid X Receptor (FXR) Ligands on the Reactivation of Latent HIV Proviruses

> **NCT05219916** · NA · TERMINATED · sponsor: **Hospices Civils de Lyon** · enrollment: 17 (actual)

## Conditions studied

- Human Immunodeficiency Virus I Infection

## Interventions

- **PROCEDURE:** Blood collection.

## Key facts

- **NCT ID:** NCT05219916
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-04-12
- **Primary completion:** 2022-07-22
- **Final completion:** 2022-07-22
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** It is unlikely that the scientific question will ever be answered. Thus, it would be considered unethical to continue the trial.
- **Last updated:** 2023-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05219916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05219916, "Selection of Farnesoid X Receptor (FXR) Ligands on the Reactivation of Latent HIV Proviruses". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05219916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*